World's Best Scientists 2026 revealed!
VIEW LIST
Louis Fehrenbacher

Louis Fehrenbacher

Kaiser Permanente
United States

D-Index & Metrics

Medicine

D-Index
84
Citations
80661
World Ranking
14804
National Ranking
7484

Louis Fehrenbacher publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Louis Fehrenbacher sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 230 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Louis Fehrenbacher D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Louis Fehrenbacher sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Louis Fehrenbacher is affiliated with Kaiser Permanente in the United States and has contributed extensively to medical research, with a focus on oncology and cancer treatment. Their work spans several main fields including Medicine and Biochemistry, Genetics and Molecular Biology. Within these areas, Fehrenbacher's research has a strong emphasis on subfields such as Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics, and Radiology, Nuclear Medicine and Imaging.

Their research topics cover a range of subjects related to cancer and pharmacology, including:

  • Cancer Treatment and Pharmacology
  • Advanced Breast Cancer Therapies
  • Breast Cancer Treatment Studies
  • Estrogen and related hormone effects
  • HER2/EGFR in Cancer Research
  • Radiopharmaceutical Chemistry and Applications
  • Brain Metastases and Treatment

Fehrenbacher has published in several respected venues, with frequent contributions to:

  • Journal of Clinical Oncology
  • Breast Cancer Research and Treatment
  • Cancer Research
  • JNCI Journal of the National Cancer Institute
  • UNC Libraries

Their recent published papers include:

  • Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study (2020, The Lancet Oncology)
  • Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease (2023, Journal of Clinical Oncology)
  • Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (2023, Journal of Clinical Oncology)
  • Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study (2021, Journal of Clinical Oncology)
  • Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer (2023, Journal of Clinical Oncology)

Throughout their career, Fehrenbacher has collaborated frequently with a number of researchers, including:

  • Norman Wolmark
  • Adam Brufsky
  • Sandra M. Swain
  • Charles E. Geyer
  • Eleftherios P. Mamounas

Best Publications

  • BEVACIZUMAB PLUS IRINOTECAN, FLUOROURACIL, AND LEUCOVORIN FOR METASTATIC COLORECTAL CANCER

    Herbert Hurwitz;Louis Fehrenbacher;William Novotny;Thomas Cartwright

  • Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

    Edward H. Romond;Edith A. Perez;John Bryant;Vera J. Suman

  • Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

    Melody A. Cobleigh;Charles L. Vogel;Debasish Tripathy;Nicholas J. Robert

  • Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

    Charles L. Vogel;Melody A. Cobleigh;Debu Tripathy;John C. Gutheil

  • Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

    Leonard B. Saltz;John V. Cox;Charles Blanke;Lee S. Rosen

  • Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

    David H. Johnson;Louis Fehrenbacher;William F. Novotny;Roy S. Herbst

  • Atezolizumab Versus Docetaxel for Patients With Previously Treated Non-Small-Cell Lung Cancer (POPLAR): A Multicentre, Open-Label, Phase 2 Randomised Controlled Trial

    Louis Fehrenbacher;Alexander Spira;Marcus Ballinger;Marcin Kowanetz

  • Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer

    Fairooz Kabbinavar;Herbert I. Hurwitz;Louis Fehrenbacher;Neal J. Meropol

  • Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

    Victor G. Vogel;Joseph P. Costantino;D. Lawrence Wickerham;D. Lawrence Wickerham;Walter M. Cronin

  • TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer

    Roy S. Herbst;Diane Prager;Robert Hermann;Lou Fehrenbacher

  • Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.

    Jennifer K. Litton;Hope S. Rugo;Johannes Ettl;Sara A. Hurvitz

  • Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

    Kathy D. Miller;Linnea I. Chap;Frankie A. Holmes;Melody A. Cobleigh

  • Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

    Bernard Fisher;James Dignam;Norman Wolmark;D Lawrence Wickerham

  • Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

    J. Philip Kuebler;H. Samuel Wieand;Michael J. O'Connell;Roy E. Smith

  • EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

    Alberto F. Sobrero;Joan Maurel;Louis Fehrenbacher;Werner Scheithauer

  • Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer: NSABP B-31

    Elizabeth Tan-Chiu;Greg Yothers;Edward Romond;Charles E. Geyer

  • Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

    David R. Gandara;Sarah M. Paul;Marcin Kowanetz;Erica Schleifman

  • Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer

    Herbert I. Hurwitz;Louis Fehrenbacher;John D. Hainsworth;William Heim

  • Multinational S tudy o f t he Efficacy a nd S afety o f H umanized Anti-HER2 M onoclonal A ntibody i n W omen W ho H ave HER2-Overexpressing M etastatic B reast C ancer T hat H as Progressed A fter C hemotherapy f or M etastatic D isease

    Melody A. Cobleigh;Charles L. Vogel;Debu Tripathy;Nicholas J. Robert

  • Efficacy a nd S afety o f T rastuzumab a s a S ingle A gent i n First-Line T reatment o f HER2 -Overexpressing M etastatic Breast C ancer

    Charles L. Vogel;Melody A. Cobleigh;Debu Tripathy;John C. Gutheil

Frequent Co-Authors

Norman Wolmark
Norman Wolmark University of Pittsburgh
Sandra M. Swain
Sandra M. Swain Georgetown University Medical Center
Joseph P. Costantino
Joseph P. Costantino University of Pittsburgh
Adam Brufsky
Adam Brufsky University of Pittsburgh
Soonmyung Paik
Soonmyung Paik Yonsei University
Eleftherios P. Mamounas
Eleftherios P. Mamounas University of Florida Health
Patricia A. Ganz
Patricia A. Ganz University of California, Los Angeles
Charles E. Geyer
Charles E. Geyer University of Pittsburgh
Julien Mazieres
Julien Mazieres Paul Sabatier University
David R. Gandara
David R. Gandara University of California, Davis

External Links

Personal website of Louis Fehrenbacher

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in the healthcare field can open up a wide range of rewarding careers beyond traditional medical degrees. For those seeking a hands-on role, direct admit nursing programs offer a streamlined entry into nursing without the need for a separate application after general studies.

If you are interested in the administrative side of healthcare, a growing option is medical billing and coding. Many students look for medical billing and coding online schools that accept financial aid, making it more accessible and affordable to launch a career in this essential field.

Prospective nurses may wonder about entrance exams. Not every program requires the TEAS or HESI exams—learn more about whether you need to take these tests with resources like do i need to take the teas test for lpn.

Those interested in leadership or management can consider earning a healthcare administration degree. There are a range of online health administration programs designed for busy professionals who want to advance their careers in the healthcare industry.

Best Scientists Citing Louis Fehrenbacher

Gabriel N. Hortobagyi

Gabriel N. Hortobagyi

The University of Texas MD Anderson Cancer Center

Publications: 140

Eric P. Winer

Eric P. Winer

Yale University

Publications: 129

Edith A. Perez

Edith A. Perez

Mayo Clinic

Publications: 110

David Cunningham

David Cunningham

Royal Marsden NHS Foundation Trust

Publications: 109

Richard M. Goldberg

Richard M. Goldberg

West Virginia University

Publications: 107

Clifford A. Hudis

Clifford A. Hudis

Memorial Sloan Kettering Cancer Center

Publications: 106

José Baselga

José Baselga

Memorial Sloan Kettering Cancer Center

Publications: 104

Axel Grothey

Axel Grothey

University of Tennessee at Knoxville

Publications: 102

Martine Piccart

Martine Piccart

Université Libre de Bruxelles

Publications: 101

Heinz-Josef Lenz

Heinz-Josef Lenz

University of Southern California

Publications: 101

Evandro de Azambuja

Evandro de Azambuja

Université Libre de Bruxelles

Publications: 99

Daniel J. Sargent

Daniel J. Sargent

Mayo Clinic

Publications: 95

Josep Tabernero

Josep Tabernero

Vall d´Hebron Institute of Oncology

Publications: 94

Nadia Harbeck

Nadia Harbeck

Ludwig-Maximilians-Universität München

Publications: 90

Hope S. Rugo

Hope S. Rugo

University of California, San Francisco

Publications: 88

Eric Van Cutsem

Eric Van Cutsem

KU Leuven

Publications: 87

Trending Scientists

Xuming Zhang

Xuming Zhang

Hong Kong Polytechnic University

Roger N. Beachy

Roger N. Beachy

Washington University in St. Louis

Eva Klopocki

Eva Klopocki

University of Würzburg

Patrizio Pasqualetti

Patrizio Pasqualetti

Sapienza University of Rome

Paul R. Houser

Paul R. Houser

George Mason University

Chenghu Zhou

Chenghu Zhou

Chinese Academy of Sciences

Robert A. Bonomo

Robert A. Bonomo

Case Western Reserve University

Liping Zhu

Liping Zhu

Chinese Academy of Sciences

Iris W. Borowsky

Iris W. Borowsky

University of Minnesota

Ishai Menache

Ishai Menache

Microsoft (United States)

Robert H. Davis

Robert H. Davis

University of Colorado Boulder

Alison J. Downard

Alison J. Downard

University of Canterbury

Libero Liggieri

Libero Liggieri

University of Florence

Roberto Gobetto

Roberto Gobetto

University of Turin

Lechosław Latos-Grażyński

Lechosław Latos-Grażyński

University of Wrocław

E. Francis Cook

E. Francis Cook

Harvard University

Related Medicine Rankings & Guides

2026 Best Online Dual FNP/PMHNP Degree Programs

2026 Best Online Dual FNP/PMHNP Degree Programs
2026 Best Paramedic-to-RN Bridge Programs

2026 Best Paramedic-to-RN Bridge Programs
2026 Best Online MSN Programs Without Clinicals

2026 Best Online MSN Programs Without Clinicals
August 2026 Best Online Doctorate in Pharmacy (PharmD.) Programs

August 2026 Best Online Doctorate in Pharmacy (PharmD.) Programs
2026 Most Affordable Online Health Information Management Degree Programs

2026 Most Affordable Online Health Information Management Degree Programs
2026 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus

2026 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus
2026 Best Online RN to BSN Programs Without Statistics

2026 Best Online RN to BSN Programs Without Statistics
2026 Most Affordable Online Medical Billing and Coding Courses

2026 Most Affordable Online Medical Billing and Coding Courses
2026 Most Affordable Online MSN in Nurse Executive Leadership Programs

2026 Most Affordable Online MSN in Nurse Executive Leadership Programs
2026 Fastest Online Graduate Certificate Nurse Midwifery Programs

2026 Fastest Online Graduate Certificate Nurse Midwifery Programs
2026 Best Online MSN/MBA Dual Degree Programs

2026 Best Online MSN/MBA Dual Degree Programs
2026 Most Affordable Online Master's Degrees in Nutrition

2026 Most Affordable Online Master's Degrees in Nutrition
2026 Fastest Online Pharmacy Technician Certificate Programs

2026 Fastest Online Pharmacy Technician Certificate Programs
2026 Easiest Radiology Programs to Get Into

2026 Easiest Radiology Programs to Get Into
2026 Best Online MSN Family Nurse Practitioner Programs

2026 Best Online MSN Family Nurse Practitioner Programs
2026 Most Affordable Online FNP Programs

2026 Most Affordable Online FNP Programs
2026 Best Online Sonography Programs

2026 Best Online Sonography Programs
2026 Best Nurse Practitioner Programs in Florida – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in Florida – Accredited Schools Online & Campus
2026 Most Affordable Healthcare Administration Degrees Online

2026 Most Affordable Healthcare Administration Degrees Online
2026 Easiest DNP Programs

2026 Easiest DNP Programs
2026 Best Shortest Online DNP Programs

2026 Best Shortest Online DNP Programs

Recently Published Articles

2026 Best Online Master’s in Entrepreneurship Programs

2026 Best Online Master’s in Entrepreneurship Programs
2026 How Long Does It Take to Earn an Online Communication Disorders Degree?

2026 How Long Does It Take to Earn an Online Communication Disorders Degree?
2026 Is a Master of Accounting Worth It? Costs & Job Opportunities

2026 Is a Master of Accounting Worth It? Costs & Job Opportunities
2026 Best Direct-Entry NP Programs for Non-Nurses

2026 Best Direct-Entry NP Programs for Non-Nurses
2026 Questions to Ask About Online Elementary Education Degree Programs Before You Enroll

2026 Questions to Ask About Online Elementary Education Degree Programs Before You Enroll
2026 How to Become an Urban Planner in Connecticut

2026 How to Become an Urban Planner in Connecticut
2026 Is an Online Criminal Justice Administration Bachelor's Degree Worth It?

2026 Is an Online Criminal Justice Administration Bachelor's Degree Worth It?
2026 How to Become a Police Detective: Education, Salary, and Job Outlook

2026 How to Become a Police Detective: Education, Salary, and Job Outlook
2026 Data Science Degree Master's Programs Accepting Students Now

2026 Data Science Degree Master's Programs Accepting Students Now
2026 How to Become a Preschool Teacher in Ohio: Requirements & Certification

2026 How to Become a Preschool Teacher in Ohio: Requirements & Certification
2026 How to Become a Licensed Therapist (LPC) in Richmond, VA

2026 How to Become a Licensed Therapist (LPC) in Richmond, VA
2026 Best Online Marketing Degree Programs

2026 Best Online Marketing Degree Programs
2026 Are Too Many Students Choosing Pharmacy? Oversaturation, Competition, and Hiring Reality

2026 Are Too Many Students Choosing Pharmacy? Oversaturation, Competition, and Hiring Reality
2026 Highest-Paying Jobs in Health Science

2026 Highest-Paying Jobs in Health Science
2026 Fastest Online Art Studies Degree Programs You Can Finish in Under 2 Years

2026 Fastest Online Art Studies Degree Programs You Can Finish in Under 2 Years
2026 How Much Does an Animal Science Degree Program Cost? Tuition, Fees & Total Expense Breakdown

2026 How Much Does an Animal Science Degree Program Cost? Tuition, Fees & Total Expense Breakdown
2026 Online Graphic Design Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations

2026 Online Graphic Design Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations
2026 Online Management Information Systems Bachelor's Degree Programs With No SAT or ACT Requirements

2026 Online Management Information Systems Bachelor's Degree Programs With No SAT or ACT Requirements
2026 Best 12-Month FNP Programs (Online & Campus)

2026 Best 12-Month FNP Programs (Online & Campus)
2026 Can You Complete an Online Engineering Degree Program While Working Full-Time?

2026 Can You Complete an Online Engineering Degree Program While Working Full-Time?
2026 Financial Aid for Online Substance Abuse Counseling Bachelor's Degrees: FAFSA, Grants, and Scholarships

2026 Financial Aid for Online Substance Abuse Counseling Bachelor's Degrees: FAFSA, Grants, and Scholarships